Search

everythinglearnresearchcommunity

for

Search:↓

Ciproterone acetate improves hair regrowth and acne in most female patients.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Sebocytes play a key role in controlling androgen levels in human skin.

Hair loss linked to higher heart disease risk in both men and women.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Higher aldosterone levels link to hair loss and high blood pressure.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Balding and low testosterone increase risk of urinary stones.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

There's no significant link between blood fat levels and male pattern baldness.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Finasteride safely lowers DHT levels without affecting testosterone.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

A new gene, JMJD1C, may affect testosterone levels in men.

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Multiple treatments work best for hair loss.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.